Bryant David Lim - Net Worth and Insider Trading

Bryant David Lim Net Worth

The estimated net worth of Bryant David Lim is at least $20,829 dollars as of 2024-05-05. Bryant David Lim is the SVP AND GENERAL COUNSEL of Aceragen Inc and owns about 30,434 shares of Aceragen Inc (ACGN) stock worth over $11,565. Bryant David Lim is also the Chief Legal Officer, Corp Sec. of Prelude Therapeutics Inc and owns about 2,400 shares of Prelude Therapeutics Inc (PRLD) stock worth over $9,264. Details can be seen in Bryant David Lim's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Bryant David Lim has not made any transactions after 2023-05-24 and currently still holds the listed stock(s).

Transaction Summary of Bryant David Lim

To

Bryant David Lim Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Bryant David Lim owns 2 companies in total, including Aceragen Inc (ACGN) , and Prelude Therapeutics Inc (PRLD) .

Click here to see the complete history of Bryant David Lim’s form 4 insider trades.

Insider Ownership Summary of Bryant David Lim

Ticker Comapny Transaction Date Type of Owner
ACGN Aceragen Inc 2021-03-25 SVP & General Counsel
PRLD Prelude Therapeutics Inc 2023-05-24 Chief Legal Counsel & Corp Sec.

Bryant David Lim Latest Holdings Summary

Bryant David Lim currently owns a total of 2 stocks. Among these stocks, Bryant David Lim owns 30,434 shares of Aceragen Inc (ACGN) as of March 25, 2021, with a value of $11,565 and a weighting of 55.52%. Bryant David Lim also owns 2,400 shares of Prelude Therapeutics Inc (PRLD) as of May 24, 2023, with a value of $9,264 and a weighting of 44.48%.

Latest Holdings of Bryant David Lim

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ACGN Aceragen Inc 2021-03-25 30,434 0.38 11,565
PRLD Prelude Therapeutics Inc 2023-05-24 2,400 3.86 9,264

Holding Weightings of Bryant David Lim


Bryant David Lim Form 4 Trading Tracker

According to the SEC Form 4 filings, Bryant David Lim has made a total of 5 transactions in Aceragen Inc (ACGN) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Aceragen Inc is the sale of 7,630 shares on March 25, 2021, which brought Bryant David Lim around $10,377.

According to the SEC Form 4 filings, Bryant David Lim has made a total of 1 transactions in Prelude Therapeutics Inc (PRLD) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Prelude Therapeutics Inc is the acquisition of 2,400 shares on May 24, 2023, which cost Bryant David Lim around $12,936.

Insider Trading History of Bryant David Lim

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Bryant David Lim Trading Performance

GuruFocus tracks the stock performance after each of Bryant David Lim's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Bryant David Lim is -14.47%. GuruFocus also compares Bryant David Lim's trading performance to market benchmark return within the same time period. The performance of stocks bought by Bryant David Lim within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Bryant David Lim's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Bryant David Lim

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -4.8
Relative Return to S&P 500(%) -12.88

Bryant David Lim Ownership Network

Ownership Network List of Bryant David Lim

No Data

Ownership Network Relation of Bryant David Lim


Bryant David Lim Owned Company Details

What does Aceragen Inc do?

Who are the key executives at Aceragen Inc?

Bryant David Lim is the SVP & General Counsel of Aceragen Inc. Other key executives at Aceragen Inc include director & President & CEO Vincent Milano , director & 10 percent owner Pillar Invest Corp , and 10 percent owner Atul Chopra .

Aceragen Inc (ACGN) Insider Trades Summary

Over the past 18 months, Bryant David Lim made no insider transaction in Aceragen Inc (ACGN). Other recent insider transactions involving Aceragen Inc (ACGN) include a net sale of 264,324 shares made by Atul Chopra , a net purchase of 21,147 shares made by Pillar Invest Corp , and a net sale of 3,283 shares made by Vincent Milano .

In summary, during the past 3 months, insiders sold 0 shares of Aceragen Inc (ACGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 273,476 shares of Aceragen Inc (ACGN) were sold and 26,965 shares were bought by its insiders, resulting in a net sale of 246,511 shares.

Aceragen Inc (ACGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Aceragen Inc Insider Transactions

No Available Data

Bryant David Lim Mailing Address

Above is the net worth, insider trading, and ownership report for Bryant David Lim. You might contact Bryant David Lim via mailing address: C/o Idera Pharmaceuticals, Inc., 505 Eagleview Blvd., Suite 212, Exton Pa 19341.

Discussions on Bryant David Lim

No discussions yet.